UPDATE ON THE MANAGEMENT OF IRRITABLE BOWEL SYNDROME
Keyword(s):
Key Word
◽
Irritable Bowel syndrome (IBS) is one of the most common diseases in gastrointestinal practice which affect seriously on the quality of life of the patients. A radical and specific therapy is not available until now. Management of IBS needs a complete approach including symptomatic, psychological and physiopathological treatment. Some new agents affecting on the receptors 5-HT3, 5-HT4 and Guanylate Cyclase have recently received approve from FDA and contributed to improve the quality of therapy of IBS. This article aims to review the recent progress in the researches and management of the IBS. Key word: Irritable Bowel syndrome (IBS)
2001 ◽
Vol 120
(5)
◽
pp. A634-A634
◽
2021 ◽
Vol 14
◽
pp. 175628482199358
2005 ◽
Vol 39
(9)
◽
pp. 807-815
◽
2021 ◽
Vol 18
(8)
◽
pp. 3888
2011 ◽
Vol 34
(6)
◽
pp. 450-458
◽